TGFB1 and cancer: Furthermore, TGF-β signaling is involved in crosstalk between cancer cells and CAFs that protect ESCC cells from several conventional chemotherapeutic agents, likely due to the transcriptional activation induced by FOXO1 which can stimulate TGF-β1 promoter activity (Zhang et al., 2017).